News Summary: Lexington Biosciences, Inc. OTCQB: (LXGTF) | CSE: (LNB)

0
302

Below is a List of Every News Release for Lexington Biosciences, Inc. OTCQB: (LXGTF) | CSE: (LNB) 

12/7/2017 | Lexington Biosciences OTCQB: (LXGTF) | CSE: (LNB) Hires Medical Device Reimbursement Experts Click Here

11/30/2017 | Lexington Biosciences OTCQB: (LXGTF) | CSE: (LNB) Engages Clinical Research Organization Click Here

10/23/2017 | Lexington Biosciences OTCQB: (LXGTF) | CSE: (LNB) Receives HeartSentry Trial Units Click Here

7/25/2017 | Lexington Biosciences Announces DTC Eligibility of OTCQB: (LXGTF) Common Shares on OTCQB Click Here


$250,000.00 by Ellis Stewart, LLC for a period beginning Jan. 1, 2018 and ending Feb. 1, 2018 to publicly disseminate information about (LXGTF). We may buy or sell additional shares of (LXGTF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares.

Read our full disclaimer here: Click Here

LEAVE A REPLY

Please enter your comment!
Please enter your name here